Candel Therapeutics
$4.98
24
+$0.06+1.22% Wednesday 20:00
Statistics
Day High
5.16
Day Low
4.91
52W High
7.25
52W Low
4.25
Volume
937,355
Avg. Volume
1,123,206
Mkt Cap
273.39M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
7MayExpected
Expected EPS
-0.305149
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-110.35MNet Income
Analyst Ratings
$20.50Average Price Target
The highest estimate is 26.00.
From 4 ratings within the last 6 months. This is not an investment recommendation.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow CADL. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Marker Therapeutics
MRKR
Mkt Cap12.78M
Nkarta
NKTX
Mkt Cap149.86M
Precigen
PGEN
Mkt Cap1.46B
Iovance Biotherapeutics
IOVA
Mkt Cap712.85M
CRISPR Therapeutics
CRSP
Mkt Cap5.82B
BioNTech
BNTX
Mkt Cap24.99B
About
Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the treatment of lung cancer, as well as has completed Phase Ib/II clinical trials for the treatment of high-grade glioma. It also develops CAN-3110, which is in Phase I clinical trials for the treatment of recurrent glioblastoma. The company was formerly known as Advantagene, Inc. and changed its name to Candel Therapeutics, Inc. in November 2020. The company was incorporated in 2003 and is based in Needham, Massachusetts.
Show more...
CEO
Dr. Paul-Peter Tak FOCIS, M.D., Ph.D.
Employees
38
Country
US
ISIN
US1374041093
Listings
0 Comments
Share your thoughts
FAQ
What is Candel Therapeutics stock price today?▼
The current price of CADL is $4.98 USD — it has increased by +1.22% in the past 24 hours. Watch Candel Therapeutics stock price performance more closely on the chart.
What is Candel Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Candel Therapeutics stocks are traded under the ticker CADL.
Is Candel Therapeutics stock price growing?▼
CADL stock has risen by +2.05% compared to the previous week, the month change is a -2.54% fall, over the last year Candel Therapeutics has showed a -6.21% decrease.
What is Candel Therapeutics market cap?▼
Today Candel Therapeutics has the market capitalization of 273.39M
When is the next Candel Therapeutics earnings date?▼
Candel Therapeutics is going to release the next earnings report on May 07, 2026.
What were Candel Therapeutics earnings last quarter?▼
CADL earnings for the last quarter are -0.54 USD per share, whereas the estimation was -0.24 USD resulting in a -120.94% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Candel Therapeutics revenue for the last year?▼
Candel Therapeutics revenue for the last year amounts to 0 USD.
What is Candel Therapeutics net income for the last year?▼
CADL net income for the last year is -110.35M USD.
How many employees does Candel Therapeutics have?▼
As of April 02, 2026, the company has 38 employees.
In which sector is Candel Therapeutics located?▼
Candel Therapeutics operates in the Health Care sector.
When did Candel Therapeutics complete a stock split?▼
Candel Therapeutics has not had any recent stock splits.
Where is Candel Therapeutics headquartered?▼
Candel Therapeutics is headquartered in Needham, US.